Logo image of CHR

CHEER HOLDING INC-A (CHR) Stock Fundamental Analysis

NASDAQ:CHR - Nasdaq - KYG399732042 - Common Stock - Currency: USD

2.676  -0.01 (-0.52%)

Fundamental Rating

5

Overall CHR gets a fundamental rating of 5 out of 10. We evaluated CHR against 71 industry peers in the Interactive Media & Services industry. CHR gets an excellent profitability rating and is at the same time showing great financial health properties. CHR is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

7

1. Profitability

1.1 Basic Checks

In the past year CHR was profitable.
CHR had a positive operating cash flow in the past year.
Each year in the past 5 years CHR has been profitable.
CHR had a positive operating cash flow in 4 of the past 5 years.
CHR Yearly Net Income VS EBIT VS OCF VS FCFCHR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 0 10M 20M 30M 40M

1.2 Ratios

CHR has a Return On Assets of 10.25%. This is amongst the best in the industry. CHR outperforms 87.88% of its industry peers.
The Return On Equity of CHR (11.94%) is better than 89.39% of its industry peers.
CHR's Return On Invested Capital of 8.84% is amongst the best of the industry. CHR outperforms 81.82% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CHR is in line with the industry average of 12.55%.
Industry RankSector Rank
ROA 10.25%
ROE 11.94%
ROIC 8.84%
ROA(3y)13.48%
ROA(5y)12.43%
ROE(3y)16.23%
ROE(5y)15.59%
ROIC(3y)12.76%
ROIC(5y)N/A
CHR Yearly ROA, ROE, ROICCHR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 0 5 10 15 20 25

1.3 Margins

Looking at the Profit Margin, with a value of 21.90%, CHR belongs to the top of the industry, outperforming 89.39% of the companies in the same industry.
CHR's Profit Margin has declined in the last couple of years.
CHR has a better Operating Margin (20.66%) than 89.39% of its industry peers.
CHR's Operating Margin has declined in the last couple of years.
The Gross Margin of CHR (73.40%) is better than 63.64% of its industry peers.
CHR's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 20.66%
PM (TTM) 21.9%
GM 73.4%
OM growth 3Y-8.13%
OM growth 5YN/A
PM growth 3Y-5.45%
PM growth 5YN/A
GM growth 3Y2.43%
GM growth 5YN/A
CHR Yearly Profit, Operating, Gross MarginsCHR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 20 40 60

More info and screens

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CHR is still creating some value.
The number of shares outstanding for CHR has been increased compared to 1 year ago.
CHR has less shares outstanding than it did 5 years ago.
The debt/assets ratio for CHR has been reduced compared to a year ago.
CHR Yearly Shares OutstandingCHR Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M
CHR Yearly Total Debt VS Total AssetsCHR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 100M 200M 300M

2.2 Solvency

CHR has an Altman-Z score of 2.92. This is not the best score and indicates that CHR is in the grey zone with still only limited risk for bankruptcy at the moment.
CHR has a Altman-Z score of 2.92. This is in the better half of the industry: CHR outperforms 71.21% of its industry peers.
The Debt to FCF ratio of CHR is 1.00, which is an excellent value as it means it would take CHR, only 1.00 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of CHR (1.00) is better than 74.24% of its industry peers.
CHR has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.00, CHR is in the better half of the industry, outperforming 65.15% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 1
Altman-Z 2.92
ROIC/WACC1.19
WACC7.44%
CHR Yearly LT Debt VS Equity VS FCFCHR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 50M 100M 150M 200M 250M

2.3 Liquidity

CHR has a Current Ratio of 6.90. This indicates that CHR is financially healthy and has no problem in meeting its short term obligations.
CHR has a better Current ratio (6.90) than 89.39% of its industry peers.
CHR has a Quick Ratio of 6.90. This indicates that CHR is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of CHR (6.90) is better than 89.39% of its industry peers.
Industry RankSector Rank
Current Ratio 6.9
Quick Ratio 6.9
CHR Yearly Current Assets VS Current LiabilitesCHR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 100M 200M 300M

More info and screens

2

3. Growth

3.1 Past

The earnings per share for CHR have decreased by -2.01% in the last year.
The Earnings Per Share has been growing by 134.27% on average over the past years. This is a very strong growth
Looking at the last year, CHR shows a small growth in Revenue. The Revenue has grown by 0.88% in the last year.
Measured over the past years, CHR shows a small growth in Revenue. The Revenue has been growing by 7.16% on average per year.
EPS 1Y (TTM)-2.01%
EPS 3Y91.81%
EPS 5Y134.27%
EPS Q2Q%5.5%
Revenue 1Y (TTM)0.88%
Revenue growth 3Y7.16%
Revenue growth 5YN/A
Sales Q2Q%5.36%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CHR Yearly Revenue VS EstimatesCHR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 50M 100M 150M
CHR Yearly EPS VS EstimatesCHR Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 0.77, the valuation of CHR can be described as very cheap.
98.48% of the companies in the same industry are more expensive than CHR, based on the Price/Earnings ratio.
CHR's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 29.62.
Industry RankSector Rank
PE 0.77
Fwd PE N/A
CHR Price Earnings VS Forward Price EarningsCHR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

CHR's Price/Free Cash Flow ratio is rather cheap when compared to the industry. CHR is cheaper than 98.48% of the companies in the same industry.
Industry RankSector Rank
P/FCF 3.34
EV/EBITDA -4.22
CHR Per share dataCHR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

The decent profitability rating of CHR may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.01
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

CHR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CHEER HOLDING INC-A

NASDAQ:CHR (2/21/2025, 8:08:46 PM)

2.676

-0.01 (-0.52%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryInteractive Media & Services
Earnings (Last)08-08 2024-08-08
Earnings (Next)N/A N/A
Inst Owners17.17%
Inst Owner ChangeN/A
Ins Owners0.74%
Ins Owner ChangeN/A
Market Cap27.54M
Analysts80
Price TargetN/A
Short Float %0.77%
Short Ratio0.35
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 0.77
Fwd PE N/A
P/S 0.18
P/FCF 3.34
P/OCF 3.34
P/B 0.1
P/tB 0.1
EV/EBITDA -4.22
EPS(TTM)3.46
EY129.3%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.8
FCFY29.96%
OCF(TTM)0.8
OCFY29.97%
SpS15.16
BVpS27.8
TBVpS26.03
PEG (NY)N/A
PEG (5Y)0.01
Profitability
Industry RankSector Rank
ROA 10.25%
ROE 11.94%
ROCE 11.19%
ROIC 8.84%
ROICexc 25.03%
ROICexgc 30.48%
OM 20.66%
PM (TTM) 21.9%
GM 73.4%
FCFM 5.29%
ROA(3y)13.48%
ROA(5y)12.43%
ROE(3y)16.23%
ROE(5y)15.59%
ROIC(3y)12.76%
ROIC(5y)N/A
ROICexc(3y)27.18%
ROICexc(5y)N/A
ROICexgc(3y)34.42%
ROICexgc(5y)N/A
ROCE(3y)16.15%
ROCE(5y)N/A
ROICexcg growth 3Y1.33%
ROICexcg growth 5Y345993%
ROICexc growth 3Y-1.03%
ROICexc growth 5Y328169%
OM growth 3Y-8.13%
OM growth 5YN/A
PM growth 3Y-5.45%
PM growth 5YN/A
GM growth 3Y2.43%
GM growth 5YN/A
F-Score4
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 1
Debt/EBITDA 0.04
Cap/Depr 0.09%
Cap/Sales 0%
Interest Coverage 82.59
Cash Conversion 23.18%
Profit Quality 24.16%
Current Ratio 6.9
Quick Ratio 6.9
Altman-Z 2.92
F-Score4
WACC7.44%
ROIC/WACC1.19
Cap/Depr(3y)136.86%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.3%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-2.01%
EPS 3Y91.81%
EPS 5Y134.27%
EPS Q2Q%5.5%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)0.88%
Revenue growth 3Y7.16%
Revenue growth 5YN/A
Sales Q2Q%5.36%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y29.21%
EBIT growth 3Y-1.56%
EBIT growth 5Y265386%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-66.99%
FCF growth 3Y91.98%
FCF growth 5YN/A
OCF growth 1Y-70.23%
OCF growth 3Y68.98%
OCF growth 5YN/A